Brookstone Capital Management

Position in HROW — Harrow, Inc.

CIK 1599584 WHEATON, IL

Position in HROW

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,323,067

+$304,618 QoQ

Shares Held

31,153

+7.9% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#71

of 223 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brookstone Capital Management holds $6,325,490 across 5 Drug Manufacturers - Specialty & Generic names. HROW ranks #2 (20.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,944	$3,220,637
2	HROW	Harrow, Inc. This page	31,153	$1,323,067
3	NBIX	Neurocrine Biosciences Inc	4,681	$788,935
4	ELAN	Elanco Animal Health Inc	31,934	$785,895
5	ZTS	Zoetis Inc.	2,880	$206,956

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,323,067	31,153	+7.9%	Shares	Sole	2026-07-15
2026-03-31	$1,018,449	28,884	-36.9%	Shares	Sole	2026-04-16
2025-09-30	$2,205,439	45,775	+232.5%	Shares	Sole	2025-10-15
2025-06-30	$420,413	13,766	+12.3%	Shares	Sole	2025-07-30
2025-03-31	$325,956	12,254	+49.7%	Shares	Sole	2025-04-29
2024-12-31	$274,707	8,188	—	Shares	Sole	2025-01-13
No filing history on record for this holder in this stock.